Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

General ticker "SHEZF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $689.2M (TTM average)

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. does not follow the US Stock Market performance with the rate: nan%.

Estimated limits based on current volatility of 0.0%: low 0.47$, high 0.47$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-05-28, amount 0.03$ (Y6.39%)
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.30$, 0.66$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.29$, 0.62$]

Short-term SHEZF quotes

Long-term SHEZF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue CNY5,445.57MM CNY5,280.71MM
Operating Expenses CNY6,306.48MM CNY4,539.40MM
Operating Income CNY-860.91MM CNY741.31MM
Non-Operating Income CNY-67.42MM CNY-15.08MM
Interest Expense CNY223.22MM CNY141.18MM
R&D Expense CNY184.66MM CNY212.04MM
Income(Loss) CNY-928.33MM CNY726.23MM
Taxes CNY-126.17MM CNY101.31MM
Profit(Loss)* CNY-783.26MM CNY646.74MM
Stockholders Equity CNY11,913.15MM CNY12,148.67MM
Inventory CNY6,654.11MM CNY5,393.95MM
Assets CNY19,203.42MM CNY17,343.52MM
Operating Cash Flow CNY398.22MM CNY2,194.13MM
Capital expenditure CNY444.88MM CNY202.77MM
Investing Cash Flow CNY1,221.57MM CNY-415.05MM
Financing Cash Flow CNY-1,210.17MM CNY-2,139.73MM
Earnings Per Share** CNY-0.53 CNY0.44

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.